Global TNF Inhibitors Market 2019-2023
- Published: Oct 2018
- Pages: 121
- SKU: IRTNTR30008
The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!
The tumor necrosis factor (TNF) inhibitors market size will grow by USD 25.74 billion during 2019-2023. This report offers an analysis of the market based on indication (TNF inhibitors for RA, TNF inhibitors for psoriasis, TNF inhibitors for IBD, and others) and geography (the Americas, APAC, and EMEA). The TNF inhibitors market research report further analyzes the market’s competitive landscape and offers information on several companies including AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, and UCB.
Below are some of the key findings from the TNF inhibitors market research report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Get a FREE sample now!
Global TNF inhibitors industry overview
TNF inhibitors have shown high efficacy in the treatment of various autoimmune disorders. Due to this high efficacy coupled with the growing prevalence of autoimmune disorders, the TNS inhibitors market pipeline is witnessing heavy investments. Various companies are focused on developing drugs to treat autoimmune disorders, with several being in the clinical trial stages. For instance, a monoclonal antibody TNF inhibitor approved for the treatment of ankylosing spondylitis is in Phase III stage of clinical trials for the treatment of juvenile rheumatoid arthritis (RA). Many of these pipeline drugs are expected to be launched during the forecast period, incrementing TNF inhibitors market size and driving the TNF inhibitors market growth.
The advent of biosimilars is one of the key TNF inhibitors market trends that will further stimulate market growth. Currently, the global TNF inhibitors market has five approved biologics. With many approved biologics nearing patent expiration, the market is witnessing an increase in the number of biosimilars. About 50 biosimilars are being developed for the treatment of various conditions, with a sizeable share for treatment of autoimmune disorders. Biosimilars are cost effective and are preferred due to their ease of access and similar efficacy to original biologics. Biosimilars get preferred treatment from regulatory authorities for their approval and launch, as they result in cost savings for the federal healthcare budget. Such approaches from regulatory authorities help in quick launch of these biosimilars, which drives the market growth. The TNF inhibitors market is expected to grow at a CAGR of almost 10% during the forecast period.
Top TNF inhibitors companies covered in this market research report
The TNF inhibitors market is moderately concentrated with a few key players occupying the majority of the market share. By offering a complete analysis of the market's competitive landscape and with information on the products offered by the companies, this TNF inhibitors industry analysis report is designed to aid clients identify and build new growth strategies.
The report offers a complete analysis of various companies including:
- Johnson & Johnson
TNF inhibitors market segmentation based on geographic regions
The Americas will lead the TNF inhibitors market share during the forecast period. Whereas, in terms of growth rate, the APAC region will witness a slightly faster momentum compared to the other regions.
TNF inhibitors market segmentation based on indication
- TNF inhibitors for RA
- TNF inhibitors for psoriasis
- TNF inhibitors for IBD
TNF inhibitors for RA will account for the largest TNF inhibitors market share during the forecast period. Whereas, TNF inhibitors for psoriasis will witness the fastest growth rate. Additionally, the report will also provide an accurate prediction of the contribution of the various segments to the growth of the TNF inhibitors market size.
Key highlights of the global TNF inhibitors market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the TNF inhibitors market during the next five years
- Precise estimation of the global TNF inhibitors market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the TNF inhibitors industry across the Americas, APAC, and EMEA
- A thorough analysis of the market's competitive landscape and detailed information on several vendors
- Comprehensive details on the factors that will challenge the growth of the TNF inhibitors companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: CUSTOMER LANDSCAPE
PART 07: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 08: MARKET SEGMENTATION BY INDICATION
- Market segmentation by indication
- Comparison by indication
- TNF inhibitors for RA - Market size and forecast 2018-2023
- TNF inhibitors for psoriasis - Market size and forecast 2018-2023
- TNF inhibitors for IBD - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by indication
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Johnson & Johnson
PART 14: APPENDIX
- Research methodology
- List of abbreviations
PART 15: EXPLORE TECHNAVIO
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get your FREE sample now!
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Did you know?
Did you know?
Did you know?
Want to customize this report?
This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.